Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Zhaoyan New Drug

Profile and portfolio

Parent Zhaoyan New Drug Research Center

Zhaoyan New Drug is the corporate venture arm of Zhaoyan New Drug Research Center, a pharmaceutical and biotech company. It invests from Series A to Series B. Sectors it names: biotech and life sciences, medical devices.

Every figure links to its source

Snapshot

Investment stage: Series A to Series B
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries A to Series B
SectorsBiotech and life sciences, Medical devices
GeographyAsia

Sources: S4 Wuxi Venture Capital: biomedicine fund completes multiple project investments; S1 Wuxi Venture Capital: Wuxi Capital and Zhaoyan set up a biomedicine industry fund.

Graphic 1 of 1

Investment stage: Series A to Series B

Sources: S4 Wuxi Venture Capital: biomedicine fund completes multiple project investments; S1 Wuxi Venture Capital: Wuxi Capital and Zhaoyan set up a biomedicine industry fund.

Download:Report a correction

Where it invests

Geography

Investment regionsS4S1

Key facts

FactValueStatusSource
Parent companyZhaoyan New Drug Research CenterSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Capital sourceParent company onlySingle sourceS1
StagesSeries A, Series B (inferred from announced rounds)EstimateS4

Fund vehicles

VehicleSizeYearSource
Wuxi Jinyi Fuxin Biomedicine FundCNY 5bn2024S1

Portfolio

Public sources name 3 portfolio companies.S4

Every company on the Zhaoyan New Drug list

3 companies, as named in the sources cited.S4 Read the firm's list.

  • Kangyuan Bochuang
  • Xingji Bio
  • Xuanjing Bio

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Wuxi Venture Capital: Wuxi Capital and Zhaoyan set up a biomedicine industry fundPress
  2. S2Zhaoyan announcement: cooperation to set up an industry fund (Jul 2024)Filing
  3. S3Pencil News: Zhaoyan invests RMB 299M in a private fundPress
  4. S4Wuxi Venture Capital: biomedicine fund completes multiple project investmentsPress

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Zhaoyan New Drug or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.